Latest Market Access News

Cleo Diagnostics has laid out a clear U.S. reimbursement pathway for its ovarian cancer test, leveraging an existing CPT code to enable early market entry and data collection ahead of FDA clearance.

American Tungsten & Antimony Ltd (ASX: AT4) has raised A$10 million through a strongly supported placement and secured a 40% Utah state tax credit, underpinning its strategy to develop a domestic US supply chain for tungsten and antimony ahead of a planned Nasdaq listing.

Provaris Energy, alongside Kawasaki Kisen Kaisha (K LINE) and Norwegian Hydrogen, has formalised a cooperation to develop a commercial hydrogen shipping supply chain from Norway to Northern Europe, focusing on cost modelling and charter terms for compressed hydrogen transport.

Titomic Limited is set to shift its corporate domicile from Australia to the United States through a scheme of arrangement, aiming to deepen its US defense market presence and access broader capital pools while maintaining its ASX listing.

Nexsen has secured a strategic partnership with GHK Hospital Limited in Hong Kong, marking a significant step in validating and commercialising its rapid point-of-care diagnostics across North Asia.

Equus Energy’s Pre-FEED study confirms the technical and commercial viability of its North West Shelf gas project, leveraging existing infrastructure to reduce costs and execution risks while targeting both LNG export and WA domestic gas markets.

Aristocrat Leisure delivered a strong half-year profit surge with 16% growth in normalised NPATA on a constant currency basis, driven by market share gains and strategic investments, while declaring a 50c interim dividend.

Energy Transition Minerals has secured a non-binding MOU with Traxys Europe for the potential exclusive offtake of tin, tantalum, and niobium concentrates from its Penouta mine, positioning the project as a strategic Western source of critical minerals.

Bioxyne has locked in a two-year, $50 million exclusive supply agreement with German pharmaceutical distributor ADREXpharma, granting exclusive rights to its Dr Watson® brand in Germany and reinforcing its foothold in Europe’s largest medicinal cannabis market.

Elixir Energy has successfully completed stimulation and commenced flow testing at its Diona-1 well in Queensland’s Surat-Bowen Basin, with gas and condensate flowing at a notable pressure. The well’s proximity to existing pipeline infrastructure could facilitate rapid commercialisation if further testing confirms sustained production.

Bioxyne expands its LATAM footprint by securing the first international medicinal cannabis flower supply agreement in Costa Rica, with initial shipments valued over $500,000 planned before June 2026.

WA Kaolin is seeking up to A$34.9 million through a fully underwritten entitlement offer aimed at restructuring its balance sheet, reducing shareholder loans, and funding operational improvements at its Wickepin kaolin project.